Selvigaltin

CAS No. 1978336-95-6

Selvigaltin( —— )

Catalog No. M35740 CAS No. 1978336-95-6

Selvigaltin (GB1211) is a Gal-3 inhibitor with potential anticancer activity. Selvigaltin is used in the study of cirrhosis and cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 656 In Stock
10MG 1121 In Stock
25MG 2366 In Stock
50MG 3674 In Stock
100MG 5543 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Selvigaltin
  • Note
    Research use only, not for human use.
  • Brief Description
    Selvigaltin (GB1211) is a Gal-3 inhibitor with potential anticancer activity. Selvigaltin is used in the study of cirrhosis and cancer.
  • Description
    Selvigaltin (GB1211) is an orally available galectin-3 (Gal-3) inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Neuropeptide Y Receptor
  • Recptor
    Neuropeptide Y Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1978336-95-6
  • Formula Weight
    533.32
  • Molecular Formula
    C19H16BrF3N4O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 12.5 mg/mL (23.44 mM; Ultrasonic (<60°C)
  • SMILES
    [H][C@@]1([C@@H](O)[C@@H](CO)O[C@H](Sc2cncc(Br)c2)[C@@H]1O)n1cc(nn1)-c1cc(F)c(F)c(F)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Slack RJ, et al. The therapeutic potential of galectin-3 inhibition in fibrotic disease. Int J Biochem Cell Biol. 2021 Jan;130:105881. ?
molnova catalog
related products
  • GW438014A

    GW438014A is a potent, selective antagonist of the NPY-Y5 receptor, effectively inhibiting food consumption and curbing body weight gain in obese rodents.

  • Neuropeptide Y(29-64...

    Neuropeptide Y(29-64) is a 36 amino acid peptide, a fragment of Neuropeptide Y.

  • SF-22

    SF-22 is a neuropeptide Y receptor (Y2R) antagonist that crosses the blood-brain barrier and has potential anti-inflammatory activity for the study of diseases associated with neurological disorders.